Register Now
The Conference
Program
Speakers
Advisory Board
Sponsors
Testimonials
Partners
Shape Your Event
Enquiries
Venue & Accommodation
Washington
Networking
Sponsorship & Exhibition
Your opportunities
Who attends
Who exhibits
Testimonials
Enquiries
Event home pages
Phacilitate home page

Partners

The vaccine field has been transformed by the technological advances of the past decade. We are now beginning to visualize the future impact of vaccines, in terms of both healthcare and economics. Expert Review of Vaccines provides structured, informed commentary on the development and application of new vaccines and vaccine technologies. It provides the key information needed by decision makers in the development and application of vaccines – from concept to clinic.

For more information go to www.future-drugs.com or email info@future-drugs.com




The field of immunotherapy is moving forward at an unprecedented rate, and a range of therapeutic approaches are now used in clinical practice, often with outstanding success. The valuable role of immunotherapy in oncology is increasingly recognized alongside conventional chemo- and radio-therapies, and the US Food and Drug Administration has approved the use of immunotherapy in melanoma, leukemias, lymphomas and myelomas, and in breast, cervical, ovarian, kidney, prostate and colorectal cancers. Immunotherapeutics are also being applied in a variety of other disease areas, including allergy, rheumatoid disease, autoimmunity and transplantation, as well as in many infections, such as HIV/AIDS and hepatitis.

Many aspects of the immune system and mechanisms of immune-modulated therapies remain to be elucidated in order to exploit fully the emerging opportunities. Those involved in the research and clinical applications of immunotherapy are challenged by the huge and intricate volumes of knowledge arising from this fast-evolving field. Immunotherapy offers the scientific community an interdisciplinary forum, providing them with concise and most recent advances of various aspects of immunotherapeutics to aid navigation of this complex field.

http://www.futuremedicine.com/loi/imt





Cancer Investigation delivers the latest translational cancer research discoveries that bridge the gap between the laboratory and the clinic. Under the expert leadership of Dr. Gary Lyman and his distinguished editorial board, Cancer Investigation is now focused to better represent the revolution in our understanding of cancer and its management.
www.informaworld.com/ci

HPV Today is a quarterly international newsletter reporting advances on HPV research with focus on the implications for the prevention of disease and clinical management of patients. HPV Today aims at disseminating information and educated opinion on the growing spectrum of conditions linked to HPV infections. A central goal of the newsletter is to contribute to the acceleration of the programs of cervical cancer prevention in the world.
HPV TODAY is an independent publication edited by a voluntary group of scientists and clinicians and distributed freely thanks to unrestricted grants from the HPV related industry.
General Coordinator: F. Xavier Bosch
Editorial Team: Alejandro Santos, Cristina Rajo, Mar García

FURTHER INFORMATION & FREE ELECTRONIC SUBSCRIPTION AT
www.hpvtoday.com




Bio-Outsourcing Asia© provides a comprehensive view of outsourcing issues facing the biopharmaceutical and biomedical industries as partnerships are formed with established and emerging Asian markets. Read about opportunities in India, China, Malaysia, Singapore, Taiwan and more. www.canbiotech.com/CBBOA.asp


BioCentury's mission is to provide value-added information and analysis for biotechnology and pharmaceutical companies, investors, academia and government on the strategic issues essential to the formation, development and sustainability of biopharmaceutical ventures. Our breadth of coverage includes corporate strategy, partnering, emerging technology, clinical data, public policy and the financing markets.

http://www.biocentury.com






Human Vaccines is a unique new peer-reviewed journal with an international audience that covers the following topics: discovery, research, enabling technologies, preclinical development, toxicology, product development, assays and quality control, process development, clinical studies, regulatory affairs, commercial, utilization, policy, safety, epidemiology, preventive vaccines, therapeutic vaccines, infectious disease targets, and non-infectious disease targets, e.g., cancer, allergy, autoimmunity. Online submission and peer review. Indexed by Medline/PubMed.

http://www.landesbioscience.com/journals/vaccines/

©Copyright Phacilitate Limited 2010





Over 50 sponsors and exhibitors participated in 2010.